The effects of the opiate antagonist naloxone on electrophysiological measures of human selective attention were examined utilizing a paradigm which dissociates selective information processing from any concurrent processes of general arousal that may be present. Subjects were injected with naloxone (2 mg, i.v.) or placebo prior to performing a three-channel selective listening task. The measure of selective attention was the difference between the auditory event-related potential (AERP) to a sequence of tones when they were attended and to the same sequence of tones when they were ignored. Typically, the AERP to attended channel tones is more negative, and this increased negativity is designated the attention effect. In this study, naloxone produced a significant augmentation of the AERP attention effect at frontal electrode sites, primarily by decreasing the negativity of AERPs to inattended tones. Naloxone had no effect on the AERPs from the undistracted and divided attention tasks or on the sensitivity of the AERP to a physical parameter of stimulus presentation, interstimulus interval. The effects of naloxone on selective attention appear to be independent of any alterations in arousal, as the drug had no effect on autonomic measures, reaction times, or auditory sensitivity, and the attention changes could be dissociated from any naloxone-induced alterations of mood. These data indicate that naloxone can have the specific effect of increasing AERP measures of selective information processing, thus suggesting a role for endogenous opioid peptides in the regulation of auditory selective attention in humans.
A long history of opiate usage in humans has facilitated our knowledge of the broad range of opiate effects. Opiates such as morphine produce not only analgesia and euphoria but also, at lower doses, the prominent effects of drowsiness, difficulty in mentation and concentration, apathy, occasional dysphoria, and lethargy (Jaffe and Martin, 1980) . These morphine actions provide clues as to some of the possible functions of the endogenous opioid peptides.
Although much animal research on opioid function has concentrated on the analgesic role of these compounds, other studies demonstrate that opioids alter an animal's response to non-noxious stimuli as well. For example, morphine diminishes the acoustic startle response (Davis, 1980) and decreases reflexive responding to sensory stimulation (Goldfarb et al., 1978) . We observed that morphine-treated rats spent less time ' in contact with stimuli in a novel environment, and this reduction was blocked by the opiate antagonist naloxone (Arnsten et al., 1981) . The administration of low doses of naloxone by itself significantly increased the time an animal spent per contact with stimuli (Arnsten and Sepal, 1979; Arnsten et al., 1981) . The stereoisomer (+)-naloxone, which has no actions at opiate receptors (Iijima et al., 1978) , had no effect on stimulus interaction (Arnsten et al., 1981) . This series of results suggested that endogenous opioid systems were involved in the regulation of stimulus-directed behavior. The prolonged stimulus contacts exhibited by naloxonetreated rats have been interpreted in terms of an opioid role in attention mechanisms (Arnsten et al., 1981) . A similar interpretation was raised in regard to another study in which morphine-treated rats made significantly more errors of commission while performing a detection task (Hernandez and Appel, 1979) . Reports of human behavioral response also suggest that opioid peptides play a role in the regulation of attention. Anecdotal reports describe morphine impairing the ability to concentrate (Jaffe and Martin, 1980) , whereas the opiate antagonist naltrexone has been shown to improve performance on a task sensitive to changes in attention and/or arousal (Gritz et al., 1976) .
Findings from electrophysiological studies of humans given opiate drugs are also consonant with an opioid role in attention regulation.
Naloxone increased, whereas morphine decreased, the amplitude of the Nl wave of the somatosensory eventrelated potential (Buchsbaum et al., 1977; Davis et al., 1982) . 2912 The Journal of Neuroscience
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The Nl wave is a negative peak, occurring approximately 100 to 150 msec after stimulus onset, which varies in amplitude according to the degree of attention allotted to the evoking stimuli, the state of arousal of the subject, and the physical properties of the evoking stimuli (Naatanen, 1975; Desmedt and Robertson, 1977; Hillyard and Picton, 1979 ).
In the current study, we examined the effects of naloxone on the auditory event-related potential (AERP) in humans, utilizing a paradigm designed to dissociate the effects of attention from those of arousal and stimulus characteristics (Hillyard et al., 1973) . In this paradigm, AERPs were recorded from subjects who listened selectively to one of three concurrently presented channels of rapidly occurring tone pips. One channel of tone pips was directed at the left ear, another at the right ear, and the third at the center of the head. Tones at each location were attended in turn, and subjects were instructed to detect occasional longer-duration target tones in the attended channel. This task resembles the classic "cocktail party" situation in which one voice is actively attended while others are ignored. The electrophysiological measure of selective attention was the difference between the AERP to the nontarget tone pips in a channel when it was attended and the AERP to the same sequence of nontarget tone pips when the channel was ignored. The amplitude of the AERP, including the Nl wave, was found to be substantially more negative when the 'tones were attended. This relative increase in the negativity elicited by attended channel tones has been designated the "attention effect." The amplitude of the attention effect has been loosely correlated with the subject's accuracy at detecting target stimuli in the attended channel(s) (Hink et al., 1977 (Hink et al., , 1978 and has been interpreted as an electrophysiological sign of the selective processing that is accorded to attended channel stimuli following an early (stimulus set) selection (e.g., Hillyard et al., 1973, Naatanen and Michie, 1979 ).
The experimental design described above provides a measure of selective attention distinct from the effects of the physical stimulus properties and changes in the state of arousal of the subject by employing the following procedures:
(1) the exact same sequence of tones was repeated for each attention condition, making the physical stimulus properties identical for attend and inattend AERPs; (2) the presentations of stimuli were randomized to prevent differential preparatory states (Naatanen, 1975) ; and (3) the order in which the different channels were attended was controlled such that each condition occurred the same average length of time from the start of the session. In addition, the tones were presented rapidly to force selective attention to only one channel.
Previous research using variations of the above paradigm has shown that the early portion of the attention effect, which overlaps the Nl wave, is largest over the central scalp (at the vertex), whereas the later negativity is more frontally distributed (Hansen and Hillyard, 1980) . In three-channel tasks such as the one employed in the present study, the early attention effect to the center channel tones was found to be smaller than the attention effects to the lateral channel tones (Schwent et al., 1976) . This finding was interpreted as resulting from the poorer discriminability of the center channel, as there is less spatial separation between the central and the lateral channels.
If naloxone were to enhance this type of selective attention in humans, we would expect it to augment the AERP attention effect and, under appropriate conditions, to improve performance on the target detection task. This hypothesis was tested in the present study, in which subjects performed the threechannel selective attention task on each of the two sessions. They received naloxone on one day and placebo on the other according to a double blind, crossover design. In order to examine the specificity of naloxone's actions on the selective aspects of attention, subjects traditionally were tested for the following naloxone-induced alterations. Undistracted and divided attention. In the undistracted or single-channel condition, a single sequence of tones was delivered to the center of the head. In the divided attention task, subjects attended to all three channels at once. The AERPs from the divided attention condition were used to create estimates of total attentional capacity. Attention researchers have proposed that the analysis of stimuli requires the allocation of attentional or processing resources from a limited pool (Kahneman, 1973; Norman and Bobrow, 1975) . When the processing demands exceed the available resources, the allocation of capacity to one aspect of the task necessarily results in a reduced allocation to others. Results from two-channel AERP attention studies were found to be consistent with limited capacity theories of attention. The summated Nl amplitudes of the AERPs to the left and right channels remained constant whether attention was focused on one of the two channels or was divided between the two (Hink et al., 1977; Okita, 1979) . This suggested that overall AERP negativity might be used as an estimate of total attentional capacity. In this study two measures of overall AERP negativity were examined as estimates of total attentional capacity: (I) the summated area of the attend and inattend waveforms across the three selective attention conditions, and (2) the summed areas of the AERPs to the left, right, and center channels from the divided attention condition.
AERP recovery functions. The amplitudes of several components of the AERP are sensitive to changes in interstimulus interval (ISI). The Nl (100 msec) and P2 (200 msec) peak amplitudes increase as a logarithmic "recovery function" of IS1 (Nelson and Lassman, 1968) . In the present study, subjects listened passively to a random sequence of tones of varying IS1 to investigate whether naloxone might alter the Nl/P2 peak amplitude recovery functions independent of any effects on attention.
Arousal and mood. Possible naloxone effects on arousal and mood were examined by looking for alterations of autonomic measures, reaction times, mood scale profiles, and global changes in attention measures, including the estimates of total attentional capacity. The results from the above series of experiments support the hypothesis that naloxone has a specific effect of enhancing the selectivity of auditory attention.
Materials and Methods
Subjects. Subjects were young (20 to 28 years) adult male undergraduate and graduate students who were paid $100 for their participation in the study. All subjects received physical examinations and demanstrated excellent health prior to acceptance in the study. Those who had abnormal hearing as determined by an audioradiogram or who were regular users of drugs such as marijuana or alcohol were omitted from the experiment.
Subjects were instructed to refrain from alcohol intake 24 hr before a test session, and those subjects who normally drank coffee were allowed one cup the morning of the experiment. The necessity of maintaining near identical conditions for the two sessions was impressed on all subjects. The general nature of the experiment was explained to them, but they were not informed of the specific hypotheses being tested. Experimental protocol. Subjects arrived at the laboratory at 9:00 AM and responded to the mood scales while electrodes were affixed to their scalps. Subjects then were seated in an easy chair inside an electrically shielded, sound-attenuating chamber. Three channels of tone pips were delivered through earphones to the left ear, the right ear, or the center of the head (binaural). Auditory thresholds for the tone pips were taken for each ear, and the three channels were adjusted to be of equal intensity.
In each of the three channels 10% of the tone pips were slightly longer in duration and were designated targets. A practice sequence of center tones only was given to familiarize the subject with the duration discrimination task. Subjects were instructed to press a button as quickly as possible each time they detected a target. Practice 2914 Arnsten et al. Vol. 4, No. 12, Dec. 1984 was continued until performance was highly accurate. In the singlechannel condition only the center channel was presented, such that subjects performed a simple duration discrimination task. In the divided attention task subjects were instructed to detect targets in all three channels at once. These five tasks were repeated twice, the second time in reverse order from the first such that all conditions occurred on the average the same length of time from injection.
The order of condition presentation was varied between subjects according to a partial Latin Square Design. Subjects were allowed brief rests between tasks.
Following attentional testing subjects were instructed to relax and listen passively to a series of tones which were randomly delivered every 0.5, 1.0, or 3.0 set to the center of the head (binaural In each channel 90% of the tone pips were 25 msec in duration (standards) while the remaining 10% in each channel were 40 msec in duration (targets). Tone intensities were 40 db SL. The identical pattern of stimulation was used for each attention task and for each subject.
In the recovery function testing, stimuli were 800-Hz tone pips of 25 msec duration.
The ISIS were 0.5, 1.0, and 3.0 set, and these occurred in random order. Stimulus intensity was 60 db SL. All sequences of tone pips were generated under computer control and were prerecorded along with coded trigger pulses on an audio tape recorder.
EEG recording and aueragirzg. Electroencephalographic activity was recorded from frontal, central, and parietal midline sites (F,, C,, and P,), and from two lateral frontal sites (left, F,, right, FJ, using AgAgCl scalp electrodes (Fig. 1) Thus, on session I, mood scales were responded to approximately 5 min after the attention testing, whereas on session II, mood scales were administered after the subjects had been seated passively for at least 20 min. Subjects receiving naloxone during session I were analyzed separately from those receiving the drug during session II to account for this difference in protocol.
Results
Selective attention. Findings from placebo sessions replicated earlier reports; a three-way repeated measures analysis of variance (3-ANOVA-R) with factors of channels (left, right, and center), attention (attend or inattend), and electrodes revealed a highly significant main effect of attention for both the early and late epochs over all three channels (early, F(1,9) = 21.56, p < 0.002; late, F(1,9) = 22.65, p < 0.001; see Figs. I-and 2). The late attention effect had a more frontal distribution, as previously described by Hansen and Hillyard (1980) (Fig. 2 ; early attention by electrode interaction, F(4,36) = 1.74, p < 0.20; late attention by electrode interaction, F(4,36) = 7.04, p < 0.003, 3-ANOVA-R).
Also consistent with previous reports (Schwent et al., 1976) , the early attention effect to the center tones was smaller than those to the lateral channels at anterior electrode sites ( Figs. 1 and 2 ; channel by electrode interaction, F&72) = 2.89, p c 0.008, 3-ANOVA-R). As seen in Figure 3 , naloxone significantly augmented the late (200 to 500 msec) attention effect primarily at anterior electrode sites (drug by electrode interaction, F(4,36) = 4.57, p < 0.005, 3-ANOVA-R on attention effect data with factors of channels, drug, and electrodes).
The early attention effect tended to be increased by naloxone, but this small effect at frontal electrode sites was not significant (drug by electrode interaction, F(4,36) = 1.46, p < 0.30, 3-ANOVA-R). The effect of naloxone on the late attention effect at the frontal sites was larger for the two lateral stimulus channels than for the center tones. To evaluate such channel-specific effects, separate 2-ANOVA-Rs were performed on the AERPs to the combined left and right channels and to the central frontal electrode sites (Table I ; drug by electrode interaction: channel (factors of drug and electrodes). Results from these F(4,36) = 4.37, p c 0.006, 2-ANOVA-R; simple main effects of analyses indicated that naloxone produced a significant augdrug: at Fq, F(1,9) = 20.41, p < 0.002, at F,, F(1,9) = 5.34, p < mentation of the late attention effect to left and right tones at 0.05, all other electrode sites not significant but had no signifi-2916 Arnsten et al. Vol. 4, No. 12, Dec. 1984 cant effects on the attention effect to the center tones (Table  I; drug by electrode interaction, F(4,36) = 1.14, p > 0.40, 2-ANOVA-R).
Nine of the 10 subjects tested displayed a larger combined left and right ear attention effect at the Fq electrode site following naloxone administration.
The significant augmentation of the combined left and right ear attention effect resulted primarily from naloxone producing a positive shift of the inattend waves at frontal electrode sites only (Table II; drug by electrode interaction, F(4,36) = 5.68, p < 0.002). Naloxone also produced a negative shift of the attend waves of all five electrode sites, but this did not reach statistical significance (Table II ; drug, F( 1,9) = 3.47, p > 0.10,2-ANOVA-RI.
In contrast to pilot study results, ceiling effects prevented a sensitive measure of naloxone's effects on target detection (e.g., mean placebo d' = 4.64). However, naloxone did produce a small but significant improvement in behavioral performance for the "attend left" condition. Subjects who received naloxone in session II performed significantly better on the attend left task that session (naloxone, d' = 4.91 f 0.84; placebo, d' = 3.71 f 0.98, tdep = 2.72, p < 0.05, two-tailed dependent t test). This improvement was due to an interaction between naloxone and practice as demonstrated by the finding that subjects who received naloxone in session I did not perform significantly better in session II (naloxone, d' = 4.49 + 0.54; placebo, d ' = 5.57 f 1.20, tdep = 1.08, not significant). Naloxone had no consistent effect on the AERP response (P300 waves) to the target tones. Undistracted and divided attention. As in the selective attention tasks, behavioral performance for the single-channel task during the placebo session was at maximum (mean d' = 4.14 + 0.41) and was unaffected by naloxone (mean d' = 4.57 f 0.37). Scores for the divided attention task were lower than those for the selective and undistracted attention tasks (mean d' = 2.57 f 0.18), but they also were not altered by naloxone in either session (mean d' = 2.58 r?r: 0.19; tdep, all p values > 0.10).
Naloxone had no effect on the AERPs to the standard tones in the undistracted (single channel) attention condition or on the two AERP estimates of attentional capacity, the summed waveforms from the divided and selective attention conditions (S-ANOVA-R, all p values > 0.25). These results suggest that naloxone did not alter the amount of attentional or processing resources available to the subject.
AERP recovery functions. Results from placebo sessions demonstrated that the length of IS1 had a highly significant effect on the amplitude of the Nl and P2 peaks, with longer ISIS being associated with target peak amplitudes ( Fig. 4 ; Nl peak: ISI, F&18) = 26.96, p < 0.00001; P2 peak: ISI, F(2,18) = 17.99, p < 0.0001, 3-ANOVA-R with factors of IS1 (0.5, 1.0, and 3.0 set), drug (naloxone and placebo), and electrodes). The effects of IS1 were largest at those scalp sites corresponding to the distribution of the Nl and P2 peaks largest effects of Nl peak at F, and C,, largest effects of P2 peak at C, and P,; IS1 by electrode interactions:
F(8,72) = 2.46 and 7.04, p < 0.02 and p < 0.00001, respectively).
Naloxone had no effect on the ampli- Mean peak amplitudes + SEM and grand average AERPs of the Nl (100 msec) and P2 (200 msec) waves evoked by stimuli occurring after one of three ISIS, 0.5, 1.0, or 3.0 sec. Peak amplitudes were increased by longer ISIS. Naloxone had no effect on this recovery function.
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tudes or the recovery functions of either the Nl or the P2 peaks ( Fig. 4 ; all p values > 0.40.). Arousal and mood. Naloxone had no effect on autonomic measures (blood pressure and pulse), auditory thresholds, or reaction times on any of the target detection attention tasks. As indicated above, the drug did not produce global changes of attention measures. Naloxone also had no significant effects on self-ratings on the mood scales, suggesting that the drug's effects on attention were not secondary to changes in arousal or mood.
Even if trends in the mood scale data are considered, naloxone's effects on mood or arousal cannot account for the drug's effects on attention.
For example, subjects who received naloxone during session II and responded to the mood scales after the 20-min passive condition tended to show positive correlations with the dysphoria scale (correlation between naloxone's effects on the AERP attention effect at F, and the dysphoria scale score: r = +0.813, p < 0.10, n = 5). In contrast, subjects who received naloxone during session I showed no correlation with the dysphoria scale (r = 0.000) but exhibited a tendency for a negative correlation with the confusion scale (r = -0.822, p > 0.10, n = 5). As naloxone administration on either of the two sessions resulted in an augmentation of the attention effect, the drug's ability to alter attention thus can be dissociated from any potential effects on mood. Interestingly, previous research also suggests that naloxone's effects on mood may be situation dependent (Byck et al., 1982) and that dysphoria may result only under conditions in which the subject is passive (Jones and Herning, 1979) .
Naloxone also tended to produce sedative effects (fatiguedrug by time interaction:
F (1,9) = 3.89, p > 0.10; inhibitiondrug by time interaction:
F(1,9) = 4.69, p > 0.10, 2-ANOVA-R with factors of drug (naloxone and placebo) and time (pre-and postinjection), n = 10). However, increased sedation cannot account for naloxone's effects on attention, as no fatiguerelated scale correlated with naloxone's alterations of the attention effect (fatigue, r = +0.250; inhibition, r = -0.338, n = 10).
Discussion
Specificity of naloxone's effects. The pattern of results revealed by this series of experiments is consistent with naloxone having a specific action of enhancing the selectivity of auditory attention. Naloxone produced a clearly significant augmentation of the late attention effect but had no effect on measures of attention in the undistracted condition or on estimates of total attentional capacity. Naloxone did not alter the recovery properties of the Nl and P2 waves, nor did it have any effect on blood pressure, pulse rate, auditory thresholds, or reaction time. The effects of naloxone on attention-related negativity appear to be independent of any naloxone effects on mood. This specificity of naloxone's effects makes it unlikely that the increase in attentional selectivity was mediated by an overall change in arousal level, which would be expected to produce more widespread changes in these electrophysiological, behavioral, and autonomic indices. This view is supported by the mood scale data in which no arousal-related scale (e.g., vigor, fatigue, inhibition) correlated with naloxone's actions on the attention effect.
Recent clinical studies of Alzheimer's patients have also found that naloxone can improve attention (Reisberg et al., 1983a, b) . Naloxone significantly improved scores on the "concentration" as well as the "memory" and "orientation" axes of the Brief Clinical Rating Scale (Reisberg et al., 1982) . Although unexpected ceiling effects impaired our ability to examine naloxone's effects on behavioral performance, the clinical findings with Alzheimer's patients are encouraging and suggest that naloxone can augment behavioral as well as electrophysiological measures of selective attention. The augmentation of the attention effect produced by naloxone resulted more from a positive shift in the inattend waves at frontal electrode sites than from a negative shift in the attend waveform. This suggests that, under the conditions of this study, naloxone improved selective attention primarily by allowing a more effective rejection of irrelevant stimuli. Whether this increase in selectivity of attention was due to a narrowing of the focus of attention at any one time or to a decrease in attentional lability (distractability) cannot be determined from these results. However, as naloxone did not alter the attention effect to the less discernable center tones, it is possible that naloxone facilitates the suppression of irrelevant stimuli only when those stimuli can be readily discriminated from the relevant tones. The low naloxone dose utilized in this study and our previous pharmacological studies in rats (Arnsten and Segal, 1979; Arnsten et al., 1981) indicate that these naloxone effects on selective attention may result from actions at opioid receptors rather than nonspecific properties of the drug. These data thus suggest a role for endogenous opioid systems in the regulation of selective attention in humans.
Possible neural mechanisms. The pattern of naloxone binding in the primate cortex has been interpreted as suggesting an opioid role in selective attention (M. E. Lewis et al., 1981; Wise and Herkenham, 1982) . Naloxone binding is lowest in primate sensory areas and increases along a gradient in relation to the degree of processing such that polysensory association areas demonstrate the densest naloxone binding (M. E. Lewis et al., 1981) . The prefrontal cortex is rich in naloxone binding (Kuhar et al., 1973; Divot et al., 1981; M. E. Lewis et al., 1981) and, in the rodent, has been shown to contain intrinsic enkephalinimmunoreactive neurons (McGinty et al., 1982) . A prefrontal cortical role in attention regulation has been indicated by the increased distractability exhibited by frontally lesioned humans (Damasio, 1979) and animals (Grueniger and Pridham, 1969) and by the supposed role of these brain regions in suppressing responses to irrelevant stimuli (Bartus and Levere, 1977; Wilcott, 1977) . Regional blood flow studies in humans indicate that the right medial prefrontal cortex in particular is active when the subject is performing a selective attention task (Roland, 1982) . It has been suggested that the prefrontal cortex modulates event-related potential attention-related negativity (Hillyard and Picton, 1979) . In line with this proposal, patients with unilateral prefrontal cortical lesions exhibited significantly smaller attention effects (Knight et al., 1981) while having normal Nl/P2 recovery functions (Knight et al., 1980) . The decrease in the attention effect in the patients of Knight et al. (1980 Knight et al. ( , 1981 appeared to result mostly from an inability to suppress negativity to inattended stimuli contralateral to the lesion, particularly for those patients with right frontal lesions. In this context it is of interest that naloxone similarly had no effect on the Nl/P2 recovery functions and increased the attention effect largely by enhancing the suppression of negativity to inattended tones. Furthermore, these naloxone actions occurred exclusively at frontal electrode sites, with the most consistent effects being observed at the right frontal (F4) electrode site. Thus, naloxone's effects may involve a facilitation of certain prefrontal cortical functions.
Previous research with rats has shown that the expression of the nalbxone response requires the presence of an intact noradrenergic (NE) system. For example, we observed that naloxone did not increase stimulus-directed behavior in rats with extensive forebrain NE depletions (Arnsten et al., 1981) . Similarly, naloxone's facilitory effects on memory were blocked by the @-receptor antagonist propanolol (Izquierdo and Graudenz, 1980) . These results are consistent with the inhibitory effects of opioids on NE transmission (Korf et al., 1974; Bird and Vol. 4, No. 12, Dec. 1984 Kuhar, 1977; Arbilla and Langer, 1978; Llorens et al., 1978; Strahlendorf et al., 1980) . It is conceivable that similar opioid/ NE interactions exist in humans and that naloxone's actions on the attention effect at least partially result from facilitation of NE transmission.
Several behavioral studies report results consistent with the interpretation that forebrain noradrenaline is necessary for an animal to ignore distracting stimuli (Roberts et al., 1975; Oke and Adams, 1978; Mason and Iversen, 1979; Lorden et al., 1980) . Consonant with these behavioral results are the electrophysiological findings which demonstrate that noradrenaline enhances the signal-to-noise ratio of responding of postsynaptic cells. Generally, the background cell activity is suppressed whereas the responses to cell-appropriate stimuli are highlighted (Foote et al., 1975; Segal and Bloom, 1976; Waterhouse et al., 1980) . This NE effect resembles naloxone's alterations of the AERPs to inattended and attended tones.
Clinical releuance. In human studies, the exposure to stressors can produce an inability to ignore irrelevant stimuli (Broadbent, 1971) , particularly during the 'performance of complex tasks (Hockey, 1970) . The stress associated with high levels of arousal is thought to narrow attentional focus and increase distractability (Kahneman, 1973) . Many reports indicate that endogenous opioid systems can be activated under conditions of stress. Exposure to stressors can promote the release of opioid peptides from the pituitary (Guillemin et al., 1977; Mueller, 1981) , adrenal medulla (Viveros et al., 1979) , and brain (Akil et al., 1976) , and can produce opiate-like, naloxonereversible effects on behavior in animals (J. W. Lewis et al., 1981) and humans (Frid et al., 1979; Willer et al., 1981) . We have observed that rats exposed to stressors exhibit morphinelike reductions in stimulus-directed behavior which are blocked by very low doses of naloxone (Arnsten et al., 1984) . It is possible that stress-induced alterations of human selective attention similarly involve an opioid mechanism.
The results presented in this paper suggest that naloxone or other opiate antagonists may be useful in the treatment of attention disorders. For example, children with attention deficit disorder (hyperkinesis) exhibit poor selective attention (American Psychiatric Association, 1980) and smaller AERP attention effects (Zambelli et al., 1977) 
